Literature DB >> 24570559

Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.

Richard Warwick1, Neeraj Mediratta, Michael Shackcloth, Richard Page, James McShane, Matthew Shaw, Michael Poullis.   

Abstract

BACKGROUND: Lobectomy remains the gold standard with regard to potentially curative resection of non-small-cell lung carcinoma. We aimed to investigate whether there is a survival difference in stage 1 non-small-cell lung cancer patients who undergo lobectomy compared to a wedge resection.
METHODS: We retrospectively analyzed a prospective database of 1283 patients who had potentially curative resection for stage 1 non-small-cell lung cancer. Only patients with adenocarcinoma, squamous or adenosquamous carcinoma were included. We benchmarked our 5-year survival against the 6th International Association for the Study of Lung Cancer results. Three techniques were used to assess the effect of a lobectomy compared to a wedge resection with regard to long-term survival: Cox multivariate regression analysis, neuronal network analysis, and propensity matching.
RESULTS: Benchmarking failed to reveal any significant difference compared to the 6th International Association for the Study of Lung Cancer results. Crude analysis demonstrated superiority of lobectomy compared to wedge resection, p = 0.02. Cox regression analysis confirmed that age, body mass index, female sex, being a current smoker, tumor diameter, and preoperative forced expiratory volume in 1 s were all significant factors determining long-term survival. Wedge resection was not a significant factor. Neuronal network analysis concurred with the Cox regression analysis. Propensity matching with 1:1 matching demonstrated that wedge resections was not inferior to a lobectomy, p = 0.10.
CONCLUSIONS: Cox regression analysis, neuronal network analysis, and propensity matching in stage 1 non-small-cell lung cancer demonstrate no difference in long-term survival after wedge resection compared to lobectomy.

Entities:  

Keywords:  Carcinoma; lung neoplasms; non-small-cell lung; pneumonectomy; survival rate; treatment outcome

Mesh:

Year:  2013        PMID: 24570559     DOI: 10.1177/0218492312466861

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  4 in total

1.  Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis.

Authors:  J Wang; H Xu; S Zhou; D Wang; L Zhu; J Hou; J Tang; J Zhao; S Zhong
Journal:  Eur J Clin Nutr       Date:  2017-05-17       Impact factor: 4.016

Review 2.  [Progress of Sublobectomy for the Treatment of Stage I Non-small Cell Lung Cancer in the Elderly].

Authors:  Siyuan Dong; Lin Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-10-20

3.  Surgical resection, radiotherapy and percutaneous thermal ablation for treatment of stage 1 non-small cell lung cancer: protocol for a systematic review and network meta-analysis.

Authors:  Arun Chockalingam; Menelaos Konstantinidis; Brandon Koo; John Timothy Moon; Andrew Tran; Sahar Nourouzpour; Emily Lawson; Kathleen Fox; Peiman Habibollahi; Bruno Odisio; Mohammed Loya; Ali Bassir; Nariman Nezami
Journal:  BMJ Open       Date:  2022-06-16       Impact factor: 3.006

Review 4.  Segmentectomy and Wedge Resection for Elderly Patients with Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Peiyu Wang; Shaodong Wang; Zheng Liu; Xizhao Sui; Xun Wang; Xiao Li; Mantang Qiu; Fan Yang
Journal:  J Clin Med       Date:  2022-01-06       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.